Organotypic culture of breast tumor explants as a multicellular system for the screening of natural compounds with antineoplastic potential

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Carranza Torres, Irma Edith ^a,b   Guzmán Delgado, Nancy Elena ^a   Coronado Martínez, Consuelo ^a   Bañuelos García, José Inocente ^a   Viveros Valdez, Ezequiel ^b   Morán Martínez, Javier ^c   Carranza Rosales, Pilar ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE COAHUILA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID; KI 67 ANTIGEN; LACTATE DEHYDROGENASE; PACLITAXEL; ROSMARINIC ACID; URSOLIC ACID; CAFFEIC ACID DERIVATIVE; CINNAMIC ACID DERIVATIVE; DEPSIDE; TRITERPENE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; BREAST TUMOR EXPLANT; CANCER SCREENING; CANCER THERAPY; CASE REPORT; CELL VIABILITY; CHEMICAL STRUCTURE; CHEMOPROPHYLAXIS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOTOXICITY; EX VIVO STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MIDDLE AGED; RESAZURIN ASSAY; TISSUE CULTURE; TISSUE PREPARATION; TISSUE SLICE; TUMOR MICROENVIRONMENT; BREAST NEOPLASMS; DRUG SCREENING; METABOLISM; PATHOLOGY; PROCEDURES; TISSUE CULTURE TECHNIQUE;

ADULT; BREAST NEOPLASMS; CAFFEIC ACIDS; CINNAMATES; DEPSIDES; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; MIDDLE AGED; TISSUE CULTURE TECHNIQUES; TRITERPENES;

EID: 84930672816     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/618021     Document Type: Article

References (81)

1. J. Ferlay, I. Soerjomataram, M. Ervik et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide in 2012: IARC Cancer Base No.11, International Agency for Research on Cancer, Lyon, France, 2013, http://globocan.iarc.fr.
2. L. Vera-Ramirez, P. Sanchez-Rovira, C. L. Ramirez-Tortosa, J. L. Quiles, M. Ramirez-Tortosa, and J. A. Lorente, "Transcriptional shif identifes a set of genes driving breast cancer chemoresis-tance," PLoS ONE, vol. 8, no. 1, Article ID e53983, 2013.
3. C. Morrissey, B. Gallis, J. W. Solazzi et al., "Efect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells," Anti-Cancer Drugs, vol. 21, no. 4, pp. 423-432, 2010.
4. G.-J. Du, Q. Dai, S. Williams, C.-Z. Wang, and C.-S. Yuan, "Synthesis of protopanaxadiol derivatives and evaluation of their anticancer activities," Anti-Cancer Drugs, vol. 22, no. 1, pp. 35-45, 2011.
5. H. J. Kang, S. H. Lee, J. E. Price, and L. S. Kim, "Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory efect of paclitaxel in a breast cancer nude mice model," The Breast Journal, vol. 15, no. 3, pp. 223-229, 2009.
6. Y. Wang, L. Rouggly, M. You, and R. Lubet, "Animal models of lung cancer: characterization and use for chemoprevention research," Progress in Molecular Biology and Translational Science, vol. 105, pp. 211-226, 2012.
7. X.-W. Yang, X.-L. Wang, L.-Q. Cao et al., "Green tea polyphenol epigallocatechin-3-gallate enhances 5-fuorouracil-induced cell growth inhibition of hepatocellular carcinoma cells," Hepatol-ogy Research, vol. 42, no. 5, pp. 494-501, 2012.
8. A. J. Alonso-Castro, M. L. Villarreal, L. A. Salazar-Olivo, M. Gomez-Sanchez, F. Dominguez, and A. Garcia-Carranca, "Mexican medicinal plants used for cancer treatment: pharmacological, phytochemical and ethnobotanical studies," Journal of Ethnopharmacology, vol. 133, no. 3, pp. 945-972, 2011.
9. K.-K. Bai, F.-L. Chen, Z. Yu, Y.-Q. Zheng, Y.-N. Li, and Y.H. Guo, "Synthesis of [3α-acetoxy-urs-12-en-28-oyl]-1-mono-glyceride and investigation on its anti tumor efects against BGC-823," Bioorganic and Medicinal Chemistry, vol. 19, no. 13, pp. 4043-4050, 2011.
10. I. Berdowska, B. Zieliński, I. Fecka, J. Kulbacka, J. Saczko, and A. Gamian, "Cytotoxic impact of phenolics from Lamiaceae species on human breast cancer cells," Food Chemistry, vol. 141, no. 2, pp. 1313-1321, 2013.
11. C. M. Kaefer and J. A. Milner, "The role of herbs and spices in cancer prevention," The Journal of Nutritional Biochemistry, vol. 19, no. 6, pp. 347-361, 2008.
12. A. Link, F. Balaguer, and A. Goel, "Cancer chemoprevention by dietary polyphenols: promising role for epigenetics," Biochemical Pharmacology, vol. 80, no. 12, pp. 1771-1792, 2010.
13. H. Wang, T. O. Khor, L. Shu et al., "Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability," Anti-Cancer Agents in Medicinal Chemistry, vol. 12, no. 10, pp. 1281-1305, 2012.
14. W. J. Lee and B. T. Zhu, "Inhibition of DNA methylation by cafeic acid and chlorogenic acid, two common catechol-containing cofee polyphenols," Carcinogenesis, vol. 27, no. 2, pp. 269-277, 2006.
15. G. L. Gierach, N. D. Freedman, A. Andaya et al., "Cofee intake and breast cancer risk in the NIH-AARP diet and health study cohort," International Journal of Cancer, vol. 131, no. 2, pp. 452-460, 2012.
16. E. Viveros-Valdez, C. Rivas-Morales, A. Oranday-Cárdenas, J. Castro-Garza, and P. Carranza-Rosales, "Antiproliferative efect from the Mexican poleo (Hedeoma drummondii)," Journal of Medicinal Food, vol. 13, no. 3, pp. 740-742, 2010.
17. D. Es-Saady, A. Simon, C. Jayat-Vignoles, A. J. Chulia, and C. Delage, "MCF-7 cell cycle arrested at G1 through ursolic acid, and increased reduction of tetrazolium salts," Anticancer Research, vol. 16, no. 1, pp. 481-486, 1996.
18. C. Martín-Cordero, M. Reyes, M. J. Ayuso, and M. V. Toro, "Cytotoxic triterpenoids from Erica andevalensis," Zeitschrif fur Naturforschung Section C: Journal of Biosciences, vol. 56, no. 1-2, pp. 45-48, 2001.
19. 2 consumption, and tumor interstitial fuid pressure," Anticancer Research, vol. 21, no. 4, pp. 2827-2833, 2001.
20. E. Kassi, T. G. Sourlingas, M. Spiliotaki et al., "Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells," Cancer Investigation, vol. 27, no. 7, pp. 723-733, 2009.
21. C.-T. Yeh, C.-H. Wu, and G.-C. Yen, "Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling," Molecular Nutrition & Food Researc, vol. 54, no. 9, pp. 1285-1295, 2010.
22. J.-Z. Shan, Y.-Y. Xuan, S.-Q. Ruan, and M. Sun, "Proliferation-inhibiting and apoptosis-inducing efects of ursolic acid and oleanolic acid on multi-drug resistance cancer cells in vitro," Chinese Journal of Integrative Medicine, vol. 17, no. 8, pp. 607-611, 2011.
23. M. A. Furtado, L. C. F. de Almeida, R. A. Furtado, W. R. Cunha, and D. C. Tavares, "Antimutagenicity of rosmarinic acid in Swiss mice evaluated by the micronucleus assay," Mutation Research- Genetic Toxicology and Environmental Mutagenesis, vol. 657, no. 2, pp. 150-154, 2008.
24. M. Shekarchi, H. Hajimehdipoor, S. Saeidnia, A. R. Gohari, and M. P. Hamedani, "Comparative study of rosmarinic acid content in some plants of Labiatae family," Pharmacognosy Magazine, vol. 8, no. 29, pp. 37-41, 2012.
25. K. Venkatachalam, S. Gunasekaran, V. A. S. Jesudoss, and N. Namasivayam, "The efect of rosmarinic acid on 1, 2-dimethylhydrazine induced colon carcinogenesis," Experimental and Toxicologic Pathology, vol. 65, no. 4, pp. 409-418, 2013.
26. J. Paluszczak, V. Krajka-Kúzniak, and W. Baer-Dubowska, "The efect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells," Toxicology Letters, vol. 192, no. 2, pp. 119-125, 2010.
27. T. P. Stanojkovíc, A. Koníc-Ristić, Z. D. Juranić et al., "Cytotoxic and cell cycle efects induced by two herbal extracts on human cervix carcinoma and human breast cancer cell lines.," Journal of medicinal food, vol. 13, no. 2, pp. 291-297, 2010.
28. Y. Xu, Z. Jiang, G. Ji, and J. Liu, "Inhibition of bone metastasis from breast carcinoma by rosmarinic acid," Planta Medica, vol. 76, no. 10, pp. 956-962, 2010.
29. S. J. Conde, R. D. A. M. Luvizotto, M. T. De Síbio, and C. R. Nogueira, "Human breast tumor slices as an alternative approach to cell lines to individualize research for each patient," European Journal of Cancer Prevention, vol. 21, no. 4, pp. 333-335, 2012.
30. I. A. M. de Graaf, P. Olinga, M. H. de Jager et al., "Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies," Nature Protocols, vol. 5, no. 9, pp. 1540-1551, 2010.
31. M. Possidente, S. Dragoni, G. Franco et al., "Rat intestinal precision-cut slices as an in vitro model to study xenobiotic interaction with transporters," European Journal of Pharmaceutics and Biopharmaceutics, vol. 79, no. 2, pp. 343-348, 2011.
32. P. Olinga and D. Schuppan, "Precision-cut liver slices: a tool to model the liver ex vivo," Journal of Hepatology, vol. 58, no. 6, pp. 1252-1253, 2013.
33. R. De Kanter, A. Tuin, E. van de Kerkhof et al., "A new technique for preparing precision-cut slices from small intestine and colon for drug biotransformation studies," Journal of Pharmacological and Toxicological Methods, vol. 51, no. 1, pp. 65-72, 2005.
34. H.-U. Kasper, V. Dries, U. Drebber, M. A. Kern, H. P. Dienes, and P. Schirmacher, "Precision cut tissue slices of the liver as morphological tool for investigation of apoptosis," In Vivo, vol. 19, no. 2, pp. 423-432, 2005.
35. P. Carranza-Rosales, M. G. Santiago-Mauricio, N. E. Guzmán-Delgado et al., "Precision-cut hamster liver slices as an ex vivo model to study amoebic liver abscess," Experimental Parasitol-ogy, vol. 126, no. 2, pp. 117-125, 2010.
36. P. Carranza-Rosales, M. G. Santiago-Mauricio, N. E. Guzmán-Delgado et al., "Induction of virulence factors, apoptosis, and cytokines in precision-cut hamster liver slices infected with Entamoeba histolytica," Experimental Parasitology, vol. 132, no. 4, pp. 424-433, 2012.
37. T. O. Kirby, A. Rivera, D. Rein et al., "A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efcacy and toxicity," Clinical Cancer Research, vol. 10, no. 24, pp. 8697-8703, 2004.
38. M. A. Stof-Khalili, A. A. Rivera, L. P. Le et al., "Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents," Cancer Gene Terapy, vol. 13, no. 6, pp. 606-618, 2006.
39. M. G. Rots, M. G. L. Elferink, W. M. Gommans et al., "An ex vivo human model system to evaluate specifcity of replicating and non-replicating gene therapy agents," The Journal of Gene Medicine, vol. 8, no. 1, pp. 35-41, 2006.
40. M. Zimmermann, S. Armeanu, I. Smirnow et al., "Human presicion-cut liver tumor slices as a tumor patient-individual predictives test system for oncolytic measles vaccine viruses," International Journal of Oncology, vol. 34, no. 5, pp. 1247-1256, 2009.
41. M. A. van Geer, K. F. D. Kuhlmann, C. T. Bakker, F. J. W. ten Kate, R. P. J. O. Elferink, and P. J. Bosma, "Ex-vivo evaluation of gene therapy vectors in human pancreatic (cancer) tissue slices," World Journal of Gastroenterology, vol. 15, no. 11, pp. 1359-1366, 2009.
42. M. A. Kern, A. M. Haugg, E. Eiteneuer et al., "Ex vivo analysis of antineoplastic agents in precision-cut tissue slices of human origin: efects of cyclooxygenase-2 inhibition in hepatocellular carcinoma," Liver International, vol. 26, no. 5, pp. 604-612, 2006.
43. P. Mestres, A. Morguet, W. Schmidt, A. Kob, and E. Tedinga, "A new method to assess drug sensitivity on breast tumor acute slices preparation," Annals of the New York Academy of Sciences, vol. 1091, pp. 460-469, 2006.
44. H. van der Kuip, T. E. Mürdter, M. Sonnenberg et al., "Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment," BMC Cancer, vol. 6, article 86, 2006.
45. N. Parajuli and W. Doppler, "Precision-cut slice cultures of tumors from MMTV-neu mice for the study of the ex vivo response to cytokines and cytotoxic drugs," In Vitro Cellular & Developmental Biology-Animal, vol. 45, no. 8, pp. 442-450, 2009.
46. R. Pazdur, A. P. Kudelka, J. J. Kavanagh, P. R. Cohen, and M. N. Raber, "The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere)," Cancer Treatment Reviews, vol. 19, no. 4, pp. 351-386, 1993.
47. D. Lister-Sharp, M. S. McDonagh, K. S. Khan, and J. Kleijnen, "A rapid and systematic review of the efectiveness and cost-efectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer," Health Technology Assessment, vol. 4, no. 17, pp. 1-113, 2000.
48. K. D. Miller and G. W. Sledge Jr., "Taxanes in the treatment of breast cancer: a prodigy comes of age," Cancer Investigation, vol. 17, no. 2, pp. 121-136, 1999.
49. C. C. Neto, A. J. Vaisberg, B.-N. Zhou, D. G. I. Kingston, and G. B. Hammond, "Cytotoxic triterpene acids from the peruvian medicinal plant Polylepis racemosa," Planta Medica, vol. 66, no. 5, pp. 483-484, 2000.
50. E. Evdokimova, H. Taper, and P. B. Calderon, "Efects of bacterial endotoxin (lipopolysaccharides) on survival and metabolism of cultured precision-cut rat liver slices," Toxicology in Vitro, vol. 16, no. 1, pp. 47-54, 2002.
51. S. Gurunathan, J. W. Han, V. Eppakayala, M. Jeyaraj, and J.-H. Kim, "Cytotoxicity of biologically synthesized silver nanopar-ticles in MDA-MB-231 human breast cancer cells," BioMed Research International, vol. 2013, Article ID 535796, 10 pages, 2013.
52. S. M. Veronese, M. Gambacorta, O. Gottardi, F. Scanzi, M. Ferrari, and P. Lampertico, "Proliferation index as a prognostic marker in breast cancer," Cancer, vol. 71, no. 12, pp. 3926-3931, 1993.
53. J. A. Hickman, R. Graeser, R. de Hoogt et al., "Tree-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo," Biotechnology Journal, vol. 9, no. 9, pp. 1115-1128, 2014.
54. J.-S. Diallo, D. Roy, H. Abdelbary, N. de Silva, and J. C. Bell, "Ex vivo infection of live tissue with oncolytic viruses," Journal of Visualized Experiments, no. 52, Article ID e2854, 2011.
55. D. L. Holliday, M. A. Moss, S. Pollock et al., "The practicalities of using tissue slices as preclinical organotypic breast cancer models," Journal of Clinical Pathology, vol. 66, no. 3, pp. 253-255, 2013.
56. F. Pirnia, S. Frese, B. Gloor et al., "Ex vivo assessment of chemotherapy-induced apoptosis and associated molecular changes in patient tumor samples," Anticancer Research, vol. 26, no. 3, pp. 1765-1772, 2006.
57. L. Horev-Azaria, G. Baldi, D. Beno et al., "Predictive Toxicology of cobalt ferrite nanoparticles: comparative in-vitro study of diferent cellular models using methods of knowledge discovery from data," Particle and Fibre Toxicology, vol. 10, no. 1, article 32, 2013.
58. C. N. Ramirez, C. Antczak, and H. Djaballah, "Cell viability assessment: toward content-rich platforms," Expert Opinion on Drug Discovery, vol. 5, no. 3, pp. 223-233, 2010.
59. S. N. Rampersad, "Multiple applications of alamar blue as an indicator of metabolic function and cellular health in cell viability bioassays," Sensors, vol. 12, no. 9, pp. 12347-12360, 2012.
60. R. Yerushalmi, R. Woods, P. M. Ravdin, M. M. Hayes, and K. A. Gelmon, "Ki67 in breast cancer: prognostic and predictive potential," The Lancet Oncology, vol. 11, no. 2, pp. 174-183, 2010.
61. C. Milani, J. Welsh, M. L. H. Katayama et al., "Human breast tumor slices: a model for identifcation of vitamin D regulated genes in the tumor microenvironment," The Journal of Steroid Biochemistry and Molecular Biology, vol. 121, no. 1-2, pp. 151-155, 2010.
62. M. Sonnenberg, H. van der Kuip, S. Haubeiß et al., "Highly variable response to cytotoxic chemotherapy in carcinoma-associated fbroblasts (CAFs) from lung and breast," BMC Cancer, vol. 8, article 364, 2008.
63. M. Kampa, V.-I. Alexaki, G. Notas et al., "Antiproliferative and apoptotic efects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action," Breast Cancer Research, vol. 6, no. 2, pp. R63-R74, 2004.
64. A. Bishayee, S. Ahmed, N. Brankov, and M. Perlof, "Triter-penoids as potential agents for the chemoprevention and therapy of breast cancer," Frontiers in Bioscience, vol. 16, no. 3, pp. 980-996, 2011.
65. P. J. Morin, "Drug resistance and the microenvironment: nature and nurture," Drug Resistance Updates, vol. 6, no. 4, pp. 169-172, 2003.
66. 2+ homeostasis and apoptosis in SCM1 human gastric cancer cells," Archives of Toxicology, vol. 87, no. 12, pp. 2141-2150, 2013.
67. T. Luo, J. Wang, Y. Yin et al., "(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma," Breast Cancer Research, vol. 12, no. 1, article R8, 2010.
68. Y. Li, D. Xing, Q. Chen, and W. R. Chen, "Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid," International Journal of Cancer, vol. 127, no. 2, pp. 462-473, 2010.
69. G.-Q. Chen, Z.-W. Yao, W.-P. Zheng, L. Chen, H. Duan, and Y. Shen, "Combined antitumor efect of ursolic acid and 5-fuorouracil on human esophageal carcinoma cell Eca-109 in vitro," Chinese Journal of Cancer Research, vol. 22, no. 1, pp. 62-67, 2010.
70. M. González-Vallinas, S. Molina, G. Vicente et al., "Antitumor efect of 5-fuorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells," Pharmacological Research, vol. 72, pp. 61-68, 2013.
71. C.-L. Lin, R.-F. Chen, J. Y.-F. Chen et al., "Protective efect of cafeic acid on paclitaxel induced anti-proliferation and apop-tosis of lung cancer cells involves NF-αb pathway," International Journal of Molecular Sciences, vol. 13, no. 5, pp. 6236-6245, 2012.
72. L. H. Lash and R. K. Zalups, "Mercuric chloride-induced cytotoxicity and compensatory hypertrophy in rat kidney proximal tubular cells," Journal of Pharmacology and Experimental Terapeutics, vol. 261, no. 2, pp. 819-829, 1992.
73. D. M. Kendig and J. B. Tarlof, "Inactivation of lactate dehydro-genase by several chemicals: implications for in vitro toxicology studies," Toxicology in Vitro, vol. 21, no. 1, pp. 125-132, 2007.
74. M. C. Hohnholt, E. M. Blumrich, and R. Dringen, "Multiassay analysis of the toxic potential of hydrogen peroxide on cultured neurons," Journal of Neuroscience Research, 2014.
75. K. Tulpule, M. C. Hohnholt, J. Hirrlinger, and R. Dringen, "Primary cultures of astrocytes and neurons as model systems to study the metabolism and metabolite export from brain cells," in Brain Energy Metabolism, J. Hirrlinger and W. S. Waagepetersen, Eds., vol. 90, pp. 45-72, Springer, New York, NY, USA, 2014.
76. M. da Silva Morrone, A. M. de Assis, R. F. da Rocha et al., "Passifora manicata (Juss.) aqueous leaf extract protects against reactive oxygen species and protein glycation in vitro and ex vivo models," Food and Chemical Toxicology, vol. 60, pp. 45-51, 2013.
77. Y. Liu, L. Cao, J. Du et al., "Protective efects of Lycium bar-barum polysaccharides against carbon tetrachloride-induced hepatotoxicity in precision-cut liver slices in vitro and in vivo in common carp (Cyprinus carpio L.)," Comparative Biochemistry and Physiology Part C: Toxicology and Pharmacology, vol. 169, pp. 65-72, 2015.
78. M. Gerlinger, A. J. Rowan, S. Horswell et al., "Intratumor heterogeneity and branched evolution revealed by multiregion sequencing," The New England Journal of Medicine, vol. 366, no. 10, pp. 883-892, 2012.
79. M. Eichelbaum, N. Spannbrucker, and H. J. Dengler, "Proceedings: N-oxidation of sparteine in man and its interindividual diferences," Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 287, supplement R94, 1975.
80. W.-Q. Ge, J.-X. Pu, and S.-Y. Zheng, "Clinical application of the adenosine triphosphate-based response assay in intravesical chemotherapy for superfcial bladder cancer," Asian Pacifc Journal of Cancer Prevention, vol. 13, no. 2, pp. 689-692, 2012.
81. C. Marquette and L. Nabell, "Chemotherapy-resistant metastat-ic breast cancer," Current Treatment Options in Oncology, vol. 13, no. 2, pp. 263-275, 2012.